Preferred Label : HhAntag691;

MeSH note : inhibits the hedgehog pathway and ABC transporters; has antineoplastic activity;

CISMeF synonym : GDC 0449; NSC 747691; R 3616; RG 3616; erivedge;

MeSH hyponym : NSC747691; NSC-747691; R3616 cpd; R-3616; GDC0449; GDC-0449; RG3616; RG-3616;

Is substance : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/vismodegib
2018
false
false
false
France
French
patient education handout
risk management
vismodegib
pregnancy
handbooks
contraception
teratogens
pregnancy tests
vismodegib
forms
abnormalities, drug-induced
fertility
fetal death
embryo death
HhAntag691
embryo loss
anilides
pyridines

---
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-12-page2-fra.php#eriv
2016
false
false
false
Canada
French
English
pharmacovigilance note
vismodegib
vismodegib
child
adolescent
vismodegib
premature epiphyseal closure
bone diseases
HhAntag691
HhAntag691
anilides
pyridines
anilides
pyridines
Contraindications, Drug

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-inhibiteurs-de-la-voie-Hedgehog-vismodegib
2016
false
false
false
France
French
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patients guideline
practice guideline
vismodegib
vismodegib
vismodegib
vismodegib
antineoplastic agents
antineoplastic agents
antineoplastic agents
carcinoma, basal cell
pregnancy
drug interactions
interdisciplinary communication
Hedgehog Signaling Pathway
signal transduction
hedgehog proteins
continuity of patient care
drug monitoring
HhAntag691
HhAntag691
HhAntag691
anilides
pyridines
anilides
pyridines
anilides
pyridines

---
http://www.has-sante.fr/portail/jcms/c_1721873/fr/erivedge-vismodegib-antineoplasique
2014
false
false
false
France
French
English
guidelines for drug use
evaluation of the transparency committee
treatment outcome
administration, oral
vismodegib
vismodegib
vismodegib
antineoplastic agents
antineoplastic agents
carcinoma, basal cell
neoplasm metastasis
adult
insurance, health, reimbursement
HhAntag691
HhAntag691
anilides
pyridines
anilides
pyridines

---
http://www.has-sante.fr/portail/jcms/c_1721873/fr/erivedge
2013
false
France
French
evaluation of the transparency committee
vismodegib
vismodegib
vismodegib
administration, oral
HhAntag691
HhAntag691
antineoplastic agents
antineoplastic agents
adult
neoplasm metastasis
carcinoma, basal cell
treatment outcome
risk management
teratogens
anilides
anilides
pyridines
pyridines

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00212
2013
false
false
false
Canada
Product containing precisely vismodegib 150 milligram/1 each conventional release oral capsule (clinical drug)
vismodegib
vismodegib
drug information
HhAntag691
anilides
pyridines

---
https://www.ema.europa.eu/medicines/human/EPAR/Erivedge
2013
false
United Kingdom
French
English
vismodegib
vismodegib
vismodegib
drug approval
europe
treatment outcome
antineoplastic agents
antineoplastic agents
adult
carcinoma, basal cell
neoplasm metastasis
administration, oral
risk management
pharmacovigilance
aged
drug interactions
pregnancy
breast feeding
contraception
teratogens
survival analysis
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed
HhAntag691
HhAntag691
anilides
anilides
pyridines
pyridines

---
Nous contacter.
18/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.